Status: current, Primitive. Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2759776016 | Rilonacept (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
2771708017 | Rilonacept | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Rilonacept | Is a | Fusion protein | true | Inferred relationship | Some | ||
Rilonacept | Is a | Recombinant interleukin 1 receptor antagonist | true | Inferred relationship | Some | ||
Rilonacept | Has disposition | Recombinant interleukin 1 receptor antagonist | true | Inferred relationship | Some | ||
Rilonacept | Is a | Immunologic agent | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Rilonacept only product | Has active ingredient | True | Rilonacept | Inferred relationship | Some | 1 |
Rilonacept 220 mg powder for solution for injection vial | Has precise active ingredient | True | Rilonacept | Inferred relationship | Some | 1 |
Rilonacept 220 mg powder for solution for injection vial | Has BoSS | True | Rilonacept | Inferred relationship | Some | 1 |
Rilonacept-containing product in parenteral dose form | Has active ingredient | True | Rilonacept | Inferred relationship | Some | 1 |
Rilonacept only product in parenteral dose form | Has active ingredient | True | Rilonacept | Inferred relationship | Some | 1 |
Rilonacept 220mg powder for injection solution 20ml vial | Has active ingredient | False | Rilonacept | Inferred relationship | Some | |
Rilonacept-containing product | Has active ingredient | True | Rilonacept | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set